Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU
NCT02205541
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Hemolytic Uremic Syndrome of Childhood
Interventions
DRUG:
Eculizumab
DRUG:
Placebo
Sponsor
University Hospital, Toulouse